Zobrazeno 1 - 8
of 8
pro vyhledávání: ''
Autor:
Marilyn K. Glassberg, Neil A. Ettinger, Hunter Gillies, Jeffrey J. Swigris, Ganesh Raghu, Roger A. Alvarez, Lisa Lancaster, Kevin R. Flaherty, Steven D. Nathan, Peter Fernandes, James E. Loyd, Parag Shah
Publikováno v:
Chest. 156:A2273-A2275
Autor:
Lisa Lancaster, Peter Fernandes, Parag Shah, Ganesh Raghu, Hunter Gillies, Bo Kim, J.E. Loyd, Kevin R. Flaherty, Roger A. Alvarez, Jeffrey J. Swigris, Neil A. Ettinger, Steven D. Nathan, Marilyn K. Glassberg
Publikováno v:
Chest. 158(2)
Background The interstitial lung diseases include a variety of disorders, many of which are characterized by fibrotic changes (fILD). Of the fILDs, Idiopathic pulmonary fibrosis is the most common. Pulmonary hypertension (PH) frequently complicates f
Autor:
Anders Heiervang Tennøe, Cathrine Brunborg, Øyvind Midtvedt, Trond Mogens Aaløkken, Øyvind Molberg, Thor Ueland, Pål Aukrust, May Britt Lund, Anna-Maria Hoffmann-Vold, Torhild Garen, Aurelija Abraityte
Publikováno v:
Chest. 150:299-306
Markers for early identification of progressive interstitial lung disease (ILD) in systemic sclerosis (SSc) are in demand. Chemokine CCL18, which has been linked to pulmonary inflammation, is an interesting candidate, but data have not been consisten
Autor:
Olivier Sitbon, Marc Humbert, Eric Hachulla, Pierre-Yves Hatron, Gérald Simonneau, Alice Bérezné, Loïc Guillevin, Pierre Clerson, Luc Mouthon, David Launay
Publikováno v:
Chest. 136:1211-1219
Background Pulmonary arterial hypertension (PAH) is a frequent cause of morbidity and mortality in patients with systemic sclerosis (SSc). PAH is generally considered to be a late complication of limited cutaneous SSc. This study identified and inves
Autor:
Masanori Kitaichi, Shigeru Tanaka, Michiaki Mishima, Tomohiro Handa, Takateru Izumi, Taishi Nagao, Michio Shigematsu, Kunio Hamada, Sonoko Nagai
Publikováno v:
Chest. 131:650-656
To evaluate the long-term clinical course of patients with idiopathic pulmonary fibrosis (IPF) complicated with pulmonary arterial hypertension.Prospective analysis of consecutive IPF patients undergoing initial workup with right-heart catheterizatio
Publikováno v:
Chest. 131:657-663
Background: Pulmonary hypertension (PH) is commonly seen in patients with idiopathic pulmonary fibrosis (IPF). We sought to examine the relationship between pulmonary function tests (PFTs), including the percentage of predicted FVC (FVC%), percentage
Autor:
Rekha Vij, Roberto F. Machado
Publikováno v:
Chest. 138(4)
Hemoglobinopathies are diseases caused by genetic mutations that result in abnormal, dysfunctional hemoglobin molecules or lower levels of normal hemoglobin molecules. The most common hemoglobinopathies are sickle cell disease (SCD) and the thalassem
Autor:
Karen L. Swanson, Jay H. Ryu, Hassan F. Nadrous, Patricia A. Pellikka, Nithima Chaowalit, Michael J. Krowka, Paul A. Decker
Publikováno v:
Chest. 128:616S-617S